Local doctor looks at latest COVID-19 vaccine developments
MILWAUKEE (CBS 58) – Pfizer’s COVID-19 vaccine is now fully approved for Americans 16 and older. More than 200 million doses of Pfizer have been administered since December, when the FDA granted it emergency use authorization.
President Joe Biden hopes this will convince those resistant to vaccines. Legal experts expect it will now be easier for companies to demand that workers be vaccinated.
“The question mark about these vaccines was, could you mandate as part of an EUA? The FDA approval removes this issue and places the vaccine mandates on a very solid legal footing, ”said Dorit Reiss, professor of law at UC Hastings.
Some wereted no time with the Pentagon, CVS, and the New York City school system announcing new terms.
The Pfizer vaccine remains subject to emergency use authorization for people aged 12 to 15, as do vaccines manufactured by Moderna and Johnson & Johnson, which are still restricted to people aged 18 and over. 60% of Americans have received at least one dose of the vaccine.
As the COVID-19 situation evolves with new guidelines, new data and new findings, it is natural to ask questions. Dr Jeff Pothof is the Quality Manager for UW Health in Madison. He joined CBS 58 Morning News to answer our questions about coronaviruses.